Literature DB >> 11074263

Cognition and synaptic plasticity in diabetes mellitus.

W H Gispen1, G J Biessels.   

Abstract

Diabetes mellitus is associated with cognitive deficits and an increased risk of dementia, particularly in the elderly. These deficits are paralleled by neurophysiological and structural changes in the brain. In animal models of diabetes, impairments of spatial learning occur in association with distinct changes in hippocampal synaptic plasticity. At the molecular level these impairments might involve changes in glutamate-receptor subtypes, in second-messenger systems and in protein kinases. The multifactorial pathogenesis of diabetic encephalopathy is not yet completely understood, but clearly shares features with brain ageing and the pathogenesis of diabetic neuropathy. It involves both metabolic and vascular changes, related to chronic hyperglycaemia, but probably also defects in insulin action in the brain. Treatment with insulin might therefore not only correct hyperglycaemia, but could also directly affect the brain.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11074263     DOI: 10.1016/s0166-2236(00)01656-8

Source DB:  PubMed          Journal:  Trends Neurosci        ISSN: 0166-2236            Impact factor:   13.837


  173 in total

1.  Differential effects of treadmill exercise in early and chronic diabetic stages on parvalbumin immunoreactivity in the hippocampus of a rat model of type 2 diabetes.

Authors:  In Koo Hwang; Sun Shin Yi; Ki-Yeon Yoo; Ok Kyu Park; Bingchun Yan; Wook Song; Moo-Ho Won; Yeo Sung Yoon; Je Kyung Seong
Journal:  Neurochem Res       Date:  2011-04-24       Impact factor: 3.996

2.  Hyperglycemia Lowers Seizure Threshold.

Authors:  Carl E. Stafstrom
Journal:  Epilepsy Curr       Date:  2003-07       Impact factor: 7.500

3.  Hippocampal memory processes are modulated by insulin and high-fat-induced insulin resistance.

Authors:  Ewan C McNay; Cecilia T Ong; Rory J McCrimmon; James Cresswell; Jonathan S Bogan; Robert S Sherwin
Journal:  Neurobiol Learn Mem       Date:  2010-02-20       Impact factor: 2.877

Review 4.  Glycogen synthase kinase-3 (GSK3): inflammation, diseases, and therapeutics.

Authors:  Richard S Jope; Christopher J Yuskaitis; Eléonore Beurel
Journal:  Neurochem Res       Date:  2006-08-30       Impact factor: 3.996

5.  Aminoguanidine changes hippocampal expression of apoptosis-related genes, improves passive avoidance learning and memory in streptozotocin-induced diabetic rats.

Authors:  Maryam Arab Firouzjaei; Mohammad Reza Jafari; Mehdi Eskandari; Iraj Jafari Anarkoli; Mohsen Alipour
Journal:  Cell Mol Neurobiol       Date:  2013-12-11       Impact factor: 5.046

Review 6.  Type 2 diabetes and risk of cognitive impairment and dementia.

Authors:  Rachel A Whitmer
Journal:  Curr Neurol Neurosci Rep       Date:  2007-09       Impact factor: 5.081

7.  Reduced hippocampal cell differentiation in the subgranular zone of the dentate gyrus in a rat model of type II diabetes.

Authors:  In Koo Hwang; Sun Shin Yi; Yo Na Kim; Il Yong Kim; In Se Lee; Yeo Sung Yoon; Je Kyung Seong
Journal:  Neurochem Res       Date:  2007-08-22       Impact factor: 3.996

8.  L-arginine and Alzheimer's disease.

Authors:  Jing Yi; Laura L Horky; Avi L Friedlich; Ying Shi; Jack T Rogers; Xudong Huang
Journal:  Int J Clin Exp Pathol       Date:  2008-10-02

9.  Effects of adult-onset streptozotocin-induced diabetes on the rat brain antioxidant status and the activities of acetylcholinesterase, (Na(+),K (+))- and Mg(2+)-ATPase: modulation by L-cysteine.

Authors:  Apostolos Zarros; Charis Liapi; Panagiota Galanopoulou; Kyriakoula Marinou; Zois Mellios; Nikolina Skandali; Hussam Al-Humadi; Foteini Anifantaki; Elena Gkrouzman; Stylianos Tsakiris
Journal:  Metab Brain Dis       Date:  2009-03-19       Impact factor: 3.584

10.  Short-term longitudinal trends in cognitive performance in older adults with type 2 diabetes.

Authors:  Ashley L Fischer; Cindy M de Frias; Sophie E Yeung; Roger A Dixon
Journal:  J Clin Exp Neuropsychol       Date:  2009-02-17       Impact factor: 2.475

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.